CP-RND AMP for ALS Public-Private Partnership (PPP)

Dear Advocates and Community Members,

We’re excited to invite you to an upcoming virtual forum to provide an update on the Critical Path for Rare Neurodegenerative Disease (CP-RND) AMP for ALS Public-Private Partnership (PPP) and its progress toward accelerating new treatments for ALS. This session, our next installment of the continuing series offering a chance for feedback and questions, will be an excellent opportunity to hear about key developments, upcoming meetings, and how the partnership and AMP are moving forward in the fight against ALS.

Details:

• Date: December 10th, 2024

• Time: 1:00 – 2:00 PM ET

• Platform: Zoom (link provided upon registration)

During the forum, Dr. Collin Hovinga, PharmD, MS, FCCP, Vice President, Rare and Orphan Disease Programs will discuss recent milestones, share updates from the PPP efforts and how they support the AMP mission, and answer any questions from the community. We encourage you to participate and engage with us in this important conversation.

Please register for the event here: registration link

If you would like to submit questions or topics for the discussion or have any issues with registration, please email me at thart@c-path.org.

We look forward to seeing you there and working together toward meaningful progress in ALS research and treatment.